Cyclosporine Lowering with Everolimus or Mycophenolate to Preserve Renal Function in Heart Recipients: a Randomized Study
Overview
Authors
Affiliations
Chou C, Chou C, Huang Y, Wu M, Hsu C, Chou Y Pharmacoepidemiol Drug Saf. 2014; 23(12):1312-9.
PMID: 25335855 PMC: 4286022. DOI: 10.1002/pds.3722.
Chronic renal insufficiency in heart transplant recipients: risk factors and management options.
Gonzalez-Vilchez F, Vazquez de Prada J Drugs. 2014; 74(13):1481-94.
PMID: 25134671 DOI: 10.1007/s40265-014-0274-9.
Everolimus in heart transplantation: an update.
Hirt S, Bara C, Barten M, Deuse T, Doesch A, Kaczmarek I J Transplant. 2014; 2013:683964.
PMID: 24382994 PMC: 3870122. DOI: 10.1155/2013/683964.
Cornu C, Dufays C, Gaillard S, Gueyffier F, Redonnet M, Sebbag L Br J Clin Pharmacol. 2013; 78(1):24-32.
PMID: 24251918 PMC: 4168377. DOI: 10.1111/bcp.12289.
Bohra R, Schoning W, Klawitter J, Brunner N, Schmitz V, Shokati T PLoS One. 2012; 7(10):e48063.
PMID: 23118926 PMC: 3485290. DOI: 10.1371/journal.pone.0048063.